Skip to content
Triangle logo TriangleGet started
← Full study record

NCT00134017 · FLOW

Participant flow

Combination Chemotherapy, Bone Marrow Transplant, and Post Transplant Cyclophosphamide for Hematologic Cancer · Source last updated 2018-08-31

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups
  1. description
    Myeloablative bone marrow transplant with a busulfan (Bu), cyclophosphamide (Cy), preparative regimen and post-transplant cyclophosphamide (PTCy) as GVHD prophylaxis.
    id
    FG000
    title
    Bone Marrow Transplant
periods
  1. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        142
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        142
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        0
      type
      NOT COMPLETED
    title
    Overall Study
Complete source fields
groups
  1. description
    Myeloablative bone marrow transplant with a busulfan (Bu), cyclophosphamide (Cy), preparative regimen and post-transplant cyclophosphamide (PTCy) as GVHD prophylaxis.
    id
    FG000
    title
    Bone Marrow Transplant
periods
  1. milestones
    1. achievements
      1. group Id
        FG000
        num Subjects
        142
      type
      STARTED
    2. achievements
      1. group Id
        FG000
        num Subjects
        142
      type
      COMPLETED
    3. achievements
      1. group Id
        FG000
        num Subjects
        0
      type
      NOT COMPLETED
    title
    Overall Study

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice